Applied Molecular Transport (AMT) is a privately held venture-backed, clinical-stage biopharmaceutical company that is applying its proprietary bioengineering technology platform to create transformative oral biological therapies for patients with severe autoimmune, inflammatory, liver and metabolic diseases. Learn More

 

Privileged Access to GI Immunology and Convergent Pathways

Learn More

Changing the Paradigm for Biologics
 

Learn More

News:

Feb 
21, 
2020

Applied Molecular Transport’s Proprietary Approach to Designing Oral Biologic Therapeutics Published in Tissue Barriers Journal | Learn More

Events:

No events scheduled at this time.